At The Future of Health Data Summit hosted by Datavant in September 2023 in Washington, D.C., Peter Slavin, Former President of Massachusetts General Hospital, called on industry leaders…

This conversation between Alice Chen, Chief Health Officer of Centene, Melanie Fontes Rainer, Director of the Office for Civil Rights, HHS, and R. Martin Chavez, Partner and Vice…

Large fit-for-purpose clinical trials remain prohibitively expensive and challenging to organize. This panel discussed building patient trust and finding alternative routes to organizing large clinical trials.

AI has the potential to touch all parts of the healthcare industry. While still in its infancy, this panel imagined scenarios for how and where to deploy AI…

What lessons have we held onto from the COVID-19 pandemic? This panel explored how the public-private partnerships that were established during the pandemic affect our current data readiness,…

Tokenizing clinical trial data in the development lifecycle allows earlier access to real-world data. Validate populations prior to marketing authorization.

Delve into the evolving landscape of digital security, focusing on phishing emails and targeted email attacks.

Specialty drugs drive the majority of prescription drug spending. Learn about capabilities unlocked by connecting SP data, first party data, and RWD.